Effects of interactions between variation in dopaminergic genes, traumatic life events, and anomalous self-experiences on psychosis proneness : results from a cross-sectional study in a nonclinical sample by Frydecka, Dorota et al.
Effects of interactions between variation in
dopaminergic genes, traumatic life events,
and anomalous self-experiences on psychosis
proneness: Results from a cross-sectional
study in a nonclinical sample
Dorota Frydecka1* , Kamila Kotowicz1 , Łukasz Gawęda2 ,
Katarzyna Prochwicz3 , Joanna Kłosowska3 , Joanna Rymaszewska1 ,
Agnieszka Samochowiec4 , Jerzy Samochowiec5 , Piotr Podwalski5 ,
Edyta Pawlak-Adamska6 , Elżbieta Szmida7 , Andrzej Cechnicki8 and
Błażej Misiak7
1Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland; 2Experimental Psychopathology Lab,
Institute of Psychology, Polish Academy of Sciences, Warsaw, Poland; 3Institute of Psychology, Jagiellonian University,
30-060 Krakow, Poland; 4Institute of Psychology, Department of Clinical Psychology, University of Szczecin, 71-017
Szczecin, Poland; 5Department of Psychiatry, Pomeranian Medical University, 71-460 Szczecin, Poland; 6Department of
Experimental Therapy, Laboratory of Immunopathology, Institute of Immunology and Experimental Therapy, Polish
Academy of Sciences, 51-114 Wroclaw, Poland; 7Department of Genetics, Wroclaw Medical University, 50-368 Wroclaw,
Poland and 8Department of Community Psychiatry, Chair of Psychiatry, Medical College Jagiellonian University, Krakow,
Poland
Abstract
Background: There is a growing number of studies showing interactions between genetic
polymorphisms associated with dopaminergic neurotransmission and traumatic life events
(TLEs) on a risk of psychotic-like experiences (PLEs). Anomalous self-experiences (ASEs) have
been associated both with TLEs as well as with PLEs. However, it remains unknown what is the
role of ASEs in the complexity of gene–environment interactions on the emergence of PLEs.
Patients andmethods:We included 445 young adults—university students from three big cities
in Poland. We used the Traumatic Events Checklist to assess TLEs, the Inventory of Psychotic-
Like anomalous self-experiences in order to measure ASEs, and the Prodromal Questionnaire
(PQ16) to record the level of PLEs. The following gene polymorphisms, related to dopaminergic
neurotransmission, were determined: the catechol-O-methyltransferase (COMT) rs4680 poly-
morphism, the dopamine D2 receptor (DRD2) rs6277 polymorphism, and the dopamine
transporter 1 (DAT1) rs28363170 polymorphism.
Results: There was a significant effect of the interaction between the DAT1 polymorphism, a
severity of ASEs, and a history of TLEs on the level of PLEs. Among the DAT1 10R/10R
homozygotes with low level of ASEs, a severity of PLEs was significantly higher in individuals
with a history of any TLEs. Higher scores of the PQ16 were associated with a greater severity of
ASEs both in the DAT1 9R allele carriers and the DAT1 10R/10R homozygotes.
Conclusion: Our findings imply that genetic liability related to aberrant dopamine transport
might impact the association between TLEs and PLEs in subjects with high levels of ASEs.
Introduction
Anomalous self-experiences (ASEs) are among the first symptoms that appear in the prodrome,
predicting the development of psychosis, and are common in peoplewith schizophrenia [1]. ASEs
have a long history in psychopathology research dating back to Bleuler, who claimed that
schizophrenia is primarily a disorder of the self [2]. Current body of research suggests that
disordered selfhood may be a central phenotypic feature of schizophrenia [2,3]. Self-disorders
present in different forms at varying magnitudes in the premorbid, prodromal, first episode,
chronic, and recovery phases of the disorder [4]. Moreover, they hyperaggregate not only in
schizophrenia but also in its spectrum diagnoses, such as schizotypal disorder, nonorganic, and
nonaffective psychoses, aswell as among first-degree relatives of schizophrenia patients [5]. Inter-
estingly, ASEs have been shown to be moderately to highly stable over time [6,7].
ASEs are disturbances in the subjective experience of the self. There are various types of ASEs,
such as disturbed sense of presence (basic self-awareness), anomalous bodily experiences (per-
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self-demarcation (confusion between oneself and other people), and
existential reorientation (self-reference), all of which are interrelated
[8]. It has been postulated that self-disturbances are manifested as
diminished self-affection and hyperreflexivity in patients with
schizophrenia [3]. Diminished self-affection refers to a disturbance
in self-agency or a diminished sense of possession of one’s experi-
ences or disturbance in the perception that one is acting out one’s
behavior. Hyperreflexivity refers to excessive attention to self-
processes that are normally experienced unconsciously [4].
ASEs have been shown to positively correlate with psychotic-
like experiences (PLEs) and self-consciousness while negatively
correlate with self-report and self-concept clarity as well as self-
esteem [1]. Higher scores are obtained in people with positive
schizotypy compared to negative schizotypy as well as in patients
with schizophrenia compared with healthy controls [1]. A prospec-
tive study on nonclinical help-seeking adolescents has shown that
ASEs can serve as a clinical marker of risk for schizophrenia-
spectrum disorder [7]. Another study on nonpsychotic young
adults has shown that a combination of high level of PLEs and
self-disturbances may capture the highest risk of psychosis in the
general population associated with cognitive biases characteristic
for psychosis [9]. In a clinical sample, ASEs have been shown to
predict the onset of schizophrenia-spectrum disorders within 5
years after hospitalization due to a nonpsychotic disorder
[10]. Moreover, a relationship between ASEs and the presence of
attenuated positive symptoms, as well as with cognitive or
cognitive-perceptive basic symptoms, was found in individuals at
clinical high risk (CHR) for psychosis [11]. Finally, ASEs were also
associated with psychosocial functioning [12], social functioning
[13], and global functioning [11,14] in CHR samples.
The dopamine hypothesis is the longest standing theory of
schizophrenia etiology, and increased striatal dopaminergic activity
is the most frequently replicated pathophysiological correlate of
psychotic symptoms [15,16]. Studies investigating the way risk
factors of psychosis affect the dopamine system, coupled with
longitudinal studies during the prodrome, allow for a more refined
understanding of what leads to the onset of psychotic disorders.
Various studies have suggested that dopaminergic abnormalities
exist in CHR individuals and include elevated peripheral dopamine
metabolites [17] or differences in dopaminergic receptor densities
[18]. It has been shown that dopamine synthesis capacity is raised in
at-risk individuals [19,20], and it is positively associated with the
severity of prodromal symptoms [21]. Moreover, antipsychotic
treatment trials have demonstrated efficacy of dopamine blockage
in reducing prodromal symptoms severity [22,23]. Numerous stud-
ies have pointed that aberrant dopamine releasemight be associated
with expression of genes-encoding proteins involved in dopamine
synthesis, metabolism, neurotransmission, and signaling [24].
Meta-analytic studies point to the association between traumatic
life events (TLEs) and the risk of psychosis [25,26] and transition to
psychosis among CHR individuals [27]. Stress has also been identi-
fied as amarker for the occurrence of subclinical psychosis in a large-
scale female twin study [28]. Moreover, it has been shown that TLEs
have an impact on dopaminergic neurotransmission. Greater striatal
dopamine release in response to social stress has been observed both
in individuals at risk of psychosis [29,30] and those with schizophre-
nia [31]. Interestingly, greater dopamine synthesis capacity [32] and
release [33] have been found among adult individuals exposed to
childhood adversity.
“Gene–environment studies have demonstrated interactions
between genetic and psychosocial risk factors for psychosis
[34]. There are several studies showing how genes associated with
dopaminergic neurotransmissionmediate the relationship between
TLEs, dopamine, and psychosis (for review, see [35]). There are also
studies showing the relationship between dopamine transmission
and ASEs as well between ASEs and PLEs. Moreover, the impact of
TLEs on disruptions of sense of self and agency has been discussed
previously [36]. However, there are no studies looking at the
between TLEs, dopamine, and psychosis proneness while taking
into account the severity of ASEs. Therefore, in this study, we aimed
to test the effect of interaction between variation in genes playing
role in dopaminergic neurotransmission (the COMT rs4680, the
DRD2 rs6277, and the DAT1 rs28363170 variable number tandem
repeat (VNTR) and TLEs on a risk of PLEs, taking into account the
impact of ASEs, in a nonclinical sample.”
Methods
Participants
A detailed description of methodological issues related to our study
was published in our previous article [37]. We included 535 under-
graduate and postgraduate university students from three big cities
in Poland (Wroclaw, Krakow, and Szczecin). A detailed description
of sampling procedures was provided in our previous articles
[9,37,38]. All participants were of Caucasian origin. The study
was approved by the Ethics Committee at Wroclaw Medical Uni-
versity. All participants gave written informed consent.
Measures
The Traumatic Events Checklist
We used the Traumatic Events Checklist to assess TLEs [39]. It is a
self-report questionnaire including 29 items. It captures six types of
traumatic events. Emotional abuse is related to being belittled, teased,
called names, threatened verbally, or unjustly punished by parents,
brothers, and sisters. Emotional neglect is related to being left alone
or insufficient affection given by parents. Physical abuse is related to
being hit, tortured, or wounded by parents, brothers, or sisters.
Threat to life refers to situations of threat to life from another person,
such as during a crime. Sexual harassment refers to acts of a sexual
nature that do not involve physical contact by parents, brothers, or
sisters. Sexual abuse is defined as unwanted sexual acts involving
physical contact by parents, brothers, or sisters.
The Inventory of Psychotic-Like Anomalous Self-Experiences
We used the Inventory of Psychotic-Like Anomalous Self-
Experiences (IPASE) in order to measure self-disorders. The IPASE
is a brief self-report alternative to phenomenological interviews that
can be used in the general population, at-risk, and clinical samples to
assess minimal self-disturbances [1]. It has been developed based on
a comprehensive phenomenological interview for self-disorders—
the Examination of Anomalous Self Experience [40]. The IPASE
consists of 57 items that can be grouped into five factors [1]. The
factor cognition consists of items related to difficulties with thought
processes. The second factor, self-awareness, and presence contain
items related to loss of basic self or identity and a loss of a connection
to the world. The third factor, consciousness, includes items about
disturbances in intentionality and difficulty with distinguishing
between imagination and reality. The fourth factor, somatization,
includes items involving disturbances in bodily experiences, such as
feeling like the bodywas changing shape or difficult to control, as well
as thought of not feeling present either psychically or physically
within one’s own body. The fifth factor, demarcation/transitivism,
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consists of items related to a disintegrating boundary between the self
and the world or a feeling of nonexistence [1]. The IPASE provides a
shorter and more easily administered alternative to phenomenolog-
ical interviews [1]. The IPASE scores are reliable and valid in a
general sample of people with high levels of schizotypy and at risk
for the future development of psychosis as well as in individuals with
schizophrenia [1].
The Prodromal Questionnaire 16
We used the 16-item Prodromal Questionnaire (PQ16) to screen
for PLEs [41]. It is a 16-item self-report questionnaire that consists
of nine items of the perceptual abnormalities/hallucinations sub-
scale, five items referring to unusual thought content/delusional
ideas/paranoia, and two negative symptoms. The perceptual aber-
rations are overrepresented since perceptual aberrations are pri-
mary psychotic phenomena, and that delusions are explanations of
these abnormal sensory experiences. Perceptual aberrations are
seen as a first phenomenon leading to psychosis. We excluded
items one and seven from data analysis because they do not capture
positive PLEs. Our analysis was limited to a number of various PLEs
experienced by participants.
Genotyping
DNA samples were obtained via buccal swabs. The single nucleo-
tide polymorphisms: COMT rs4680 (Val158Met) and the DRD2
rs6277 (957C>T) were genotyped with the allelic discrimination
technique with the use of validated and predesigned TaqMan®SNP
Genotyping Assays (C__25746809_50 and C__11339240_10)
according to the manufacturer’s instructions (ThermoFisher Sci-
entific, Inc., USA). DAT1 VNTR rs28363170 polymorphism was
genotyped through PCRwith pair of primer, where the forward one
was labeled with 6-FAM followed by capillary electrophoresis in the
presence of the GeneScan™ 600 LIZ® Size Standard on 3500 Genetic
Analyzer (Applied Biosystems). Individual genotypes were called
according to peak size onGeneMapper® Software version 4.0., being
the 9-allele (440 bp) and the 10-allele (480 bp).
Statistics
Agreement of genotypes distribution with the Hardy–Weinberg
equilibrium (HWE) was assessed by comparing observed and
expected distributions using the χ2 test. Bivariate comparisons were
performed using the Mann–Whitney U test. The Spearman rank
correlation coefficients were used to assess correlations. Multiple
linear regression was performed to test the effects of variation in
dopaminergic genes and a history of any TLEs on the number of
PLEs. Main effects were represented by a history of any TLEs, the
allele status (COMT: the Met allele carriers vs. the Val/Val homo-
zygotes;DRD2: the C allele carriers vs. the TT homozygotes;DAT1:
the 9R allele carriers vs. the 10R/10R homozygotes), and the level of
ASEs. The level of ASEs was dichotomized to high level (individuals
scored above the mean score of the IPASE) and low level (individ-
uals scored below the mean score of the IPASE). Age and sex were
added as covariates. Indeed, the onset of psychosis usually appears
in the adolescence or early adulthood [42]. In turn, sex differences
might impact various clinical characteristics of individuals at clin-
ical high risk of psychosis [43]. Firstly, we tested the effects of
covariates (the first block of independent variables, model 1). Next,
the main effects were implemented (the second block of indepen-
dent variables, model 2). The third block of independent variables
(model 3) included the two-way interactions (allele statusTLEs,
allele statusASEs, and TLEsASEs). Finally, we inputted the
three-way interaction term (allele statusTLEsASEs, model 4).
Posthoc analyses were based on bivariate comparisons using
the Mann–Whitney U test. Results were considered significant if
the p-value was less than 0.05. Statistical analysis was performed
using the Statistical Package for Social Sciences, version 20 (SPSS,
Inc., Chicago, Illinois, USA).
Results
General characteristics of participants were presented in Table 1.
Distribution of the COMT rs4680 and the DAT1 VNTR 9R/10R
genotypes was in agreement with the HWE (COMT: χ2 = 0.07, p =
0.791; DAT1 9R/10R VNTR: χ2 = 1.78, p =0.183). However, the
distribution of the DRD2 genotypes did not follow the HWE (χ2 =
6.31, p =0.012). As expected, a history of TLEs was associated with
significantly higher scores of the IPASE (Table 2). There were
significant positive correlations between the IPASE scores and
the PQ16 score (Table 3).
Results of multiple linear regression were presented in Table 4.
There were significant main effects of age and a severity of ASEs on
the PQ16 scores in all models. The effect of a history of TLEs on the
PQ16 score was significant only in the model 2 for all tested gene
polymorphisms. No significant main effects of gene polymor-
phisms on the PQ16 scores were found. However, there was a
significant effect of the interaction between the DAT1 9R/10R
VNTR and a severity of ASEs on the PQ16 score (model 4). Effects
of the interaction between a history of TLEs and the level of ASEs on
the PQ16 score were significant in themodels 3 and 4 for theCOMT
Table 1. General characteristics of the sample.
MeanSD or n (%)
Age, years 23.4 3.0
Sex (M/F) 129 (29.0)/316 (71.0)
Clinical diagnosis 38 (8.5)
TEC (positive history of any TLEs) 253 (56.8)
PQ-16 (total score) 5.4 5.4
PQ-16 (without items 1 and 7) 4.2 4.6













Abbreviations: ASE, anomalous self-experience; COMT, catechol-O-methyltransferase; DAT1,
dopamine transporter 1; DRD2, dopamine D2 receptor; PQ-16, Prodromal Questionnaire 16;
TEC, Traumatic Events Checklist; TLEs, traumatic life events; SD, standard deviation.
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rs4680 and the DRD2 rs6277 polymorphisms. Similarly, the effects
of a three-way interaction (the DAT1 9R/10R allele statusTLEs
ASEs) on the PQ16 score were also significant. The model 4 that
included the DAT1 9R/10R allele status explained the largest pro-
portion of variance in the PQ16 score (R2 = 0.355).
Results of posthoc analyses were shown in Figure 1 and Sup-
plementary Material. Higher scores of the PQ16 were associated
with a greater severity of ASEs both in the DAT1 9R allele carriers
and the DAT1 10R/10R homozygotes (p< 0.001,Figure 1 and Sup-
plementary Table 1). In participants with a high level of ASEs, a
history of TLEs was associated with significantly higher scores of
PQ16 in the DAT1 10R/10R homozygotes (8.36 6.06 vs. 4.47
3.34, p= 0.015) but not in theDAT1 9R allele carriers (Figure 1 and
Supplementary Table 2). These results were not significant in the
group with low levels of ASEs.
Model 4 for DAT1 explained the largest proportion of variance
in the PQ16 score measured by the R2 statistic (Table 4). Adding a
three-way interaction term significantly increased the R2 statistic.
In turn, adding a three-way interaction term to the models with the
DRD2 and COMT polymorphisms did not change the R2 statistic
significantly.
Discussion
In our previous articles, we have shown that a path from trauma to
psychosis proneness leads via cognitive biases and self-disorders
[38] and that the combination of high level of PLEs together with
self-disturbances captures the highest risk of psychosis in the
general population [9]. Our main finding from genetic studies so
far was that among participants with high levels of cognitive biases,
there is an interaction between COMT gene polymorphism and a
history of TLEs on the severity of PLEs [37]. In our current study,
we wanted to see whether not only the level of cognitive biases but
also the level of self-disorders influence the interaction between
genetic polymorphisms in the genes influencing dopaminergic
neurotransmission (COMT, DRD2, and DAT1) and a history of
TLEs on the severity of PLEs.
Findings from our study imply that TLEsmight increase severity
of PLEs only in 10R/10R homozygotes of the DAT1 9R/10R VNTR
polymorphism. DAT1 is a protein regulating dopamine synaptic
levels by limiting dopamine receptor activation and facilitating
neuronal dopamine reuptake. Several DAT1 gene polymorphisms
have been described, among these, there is a 40 bp VNTR that most
commonly occurs as 9 or 10 tandem repeats (R). There is evidence
that this polymorphism is functional, altering gene expression.
According to current models, reduced DAT1 expression should
amplify phasic DA signals [44]. It has been found that healthy
individuals with the DAT1 10R/10R genotype show lower striatal
transporter binding [45], while the DAT1 9R allele carriers present
with increased striatal dopamine transporter availability [46,47]. A
recent meta-analysis confirmed that the DAT1 9R/10R VNTR
polymorphism regulates dopamine activity in the striatal brain
regions independent of the presence of neuropsychiatric illnesses
[48]. Thus, it can be hypothesized that additionally to increased
striatal dopamine activity associated with theDAT1 gene polymor-
phism, exposure to TLEs further increases dopaminergic neuro-
transmission, leading to increased risk of PLEs. This is in line with
schizophrenia risk model which requires two hits in order to
generate the clinical phenotype. The first hit is associated with early
priming in a genetically predisposed individuals, while the second
hit is usually an environmental insult occurring at certain neuro-
developmental stages [49]. Although neither population-based
association study [50] nor family-based association study [51]
showed the significance of theDAT1 9R/10RVNTR polymorphism
in the development of schizophrenia, these studies did not control
for the effects of TLEs. Partially, the interaction between TLEs and
the DAT1 polymorphism could be due to the fact that genetic
variants in dopaminergic genes are associated with considerable
interindividual variation in the ability to acquire and extinguish
conditioned fear reactions [52]. In particular, it has been shown that
higher learning rates during fear extinction are observed in the
DAT1 9R-carriers as compared to noncarriers [53].
There are few studies so far showing that the DAT1 polymor-
phisms are associated with negative experiences in the childhood
and negative parenting. A study on male and female twins showed
that men with the 9R/9R genotype report less sexual abuse experi-
ences in comparison to other genotypes, while in women, there was
an association between the 9R/9R genotype with less experiences of
emotional abuse in comparison to other genotypes [54]. These
results suggest that either some experiences of childhood abuse
may be genetically influenced, or children carrying the specific
genotype have temperamental traits that make them more vulner-
able to abuse. Another scenario is that children inherit from their
parent the genotype that is associated with certain behavior (e.g.,
antisocial behavior). On the other hand, the association between
maternal DAT1 9R/10R genotype and negative parenting has been
found and appeared to be significantly stronger among mothers
whose children were highly disruptive and noncompliant during
themother–child interactions, suggesting gene–environment inter-
action [55].
Table 2. The IPASE scores with respect to a history of TLEs.
IPASE TLEs (+) TLEs ()
IPASE—cognition 9.8  4.1 8.5  2.7
IPASE—self-awareness 36.4  14.8 30.6  10.0
IPASE—consciousness 13.7  5.0 11.0  4.4
IPASE—somatic 28.1  10.4 24.1  8.0
IPASE—demarcation/transitivism 7.9  3.0 6.8  2.3
IPASE—total score 95.9  33.6 80.9  24.1
PQ16 score 4.9  5.1 3.1  3.7
Abbreviations: IPASE, inventory of psychotic-like anomalous self-experiences; PQ-16,
Prodromal Questionnaire 16; TLEs, traumatic life events.
Data expressed as meanSD.
p < 0.001 for all comparisons.
Table 3. Correlations between the IPASE scores and the PQ16 score.
The IPASE score PQ16
Cognition r = 0.479
Self-awareness r = 0.515
Consciousness r = 0.549
Somatic r = 0.550
Demarcation/transitivism r = 0.430
Total score r = 0.590
Abbreviations: IPASE, inventory of psychotic-like anomalous self-experiences; PQ-16,
Prodromal Questionnaire 16.
Spearman’s rank correlation coefficients.
p < 0.001 for all correlations.
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There are also mixed findings from studies showing an interac-
tion between negative experiences and psychiatric symptomatology
in nonpsychotic disorders. There is evidence that an interaction
between the DAT1 VNTR polymorphism and TLEs has an impact
on symptomatology in attention deficit hyperactivity disorder
(ADHD) patients. The authors showed that adolescents being
homozygous for the 10R of the DAT1 VNTR polymorphism who
grew up in greater psychosocial adversity exhibit significantly more
ADHD symptoms in comparison to adolescents with other geno-
types or who lived in less adverse family environments [56]. On the
other hand, it has been shown that children with 10R/10R genotype
have lower level of conduct problems under the condition of low
level of positive maternal emotions than those patients with the
9R/9R and 10R/9R genotypes [57]. The DAT1 gene 9R variant has
been associated with child negative affect expressed toward the
parent during parent–child interactions, and parents of children
with the 9R allele have been found to exhibit more hostility and
lower guidance/engagement than parents of children without the
9R allele [58]. Moreover, the DAT1 single nucleotide polymor-
phism (rs40184) has been shown tomoderate the effect of perceived
maternal rejection on the onset of major depressive disorder and
suicidal ideation in male adolescents [59].
Our further analysis revealed that the interaction between TLEs
and the DAT1 polymorphism appears only in individuals with high
levels of ASEs. Although there are no studies so far that directly
associate dopaminergic neurotransmission with ASEs, it has been
shown that self-awareness is regulated by dopamine [60,61] via the
GABA system through the medial prefrontal cortex and anterior
cingulate cortex [62] (for review, see [63]). The current model of
ASEs is based on a combination of empirical findings, clinical expe-
rience, and phenomenological considerations; however, there is a
growing body of research trying to link phenomenology with neuro-
biology despite technical and conceptual challenges (for review, see
[64]). A meta-analytic study showed that the cortical midline system
may be responsible for the self-referential processing—basic sense of
self—and changes in this region are related to psychotic symptoms as
well as they are among the earliest alterations observed in schizo-
phrenia [65]. Aberrant dopamine transmission is thought to disturb
the salience of external and internal stimuli, and self-disturbances and
psychotic symptoms may arise as patients experience these
Table 4. Results of multiple linear regression analysis.
Model Effect
DAT1 COMT DRD2
R2/ΔR2 B SE p R2/ΔR2 B SE p R2/ΔR2 B SE
1 Age 0.103/0.103* 0.449 0.083 <0.001 0.110/0.110* 0.454 0.068 <0.001 0.115/0.115* 0.475 0.070
Sex 0.693 0.549 0.207 0.728 0.452 0.108 0.839 0.466
2 Age 0.324/0.221* 0.347 0.073 <0.001 0.311/0.201* 0.335 0.061 <0.001 0.314/0.199* 0.350 0.063
Sex 0.672 0.479 0.162 0.651 0.399 0.104 0.722 0.412
ASEs 4.349 0.458 <0.001 3.776 0.381 <0.001 3.838 0.390
TLEs 0.958 0.447 0.033 1.168 0.361 0.001 1.275 0.372
Allele 0.239 0.436 0.583 0.336 0.416 0.420 0.747 0.406
3 Age 0.337/0.013 0.342 0.073 <0.001 0.330/0.018* 0.348 0.061 <0.001 0.332/0.018* 0.359 0.063
Sex 0.654 0.477 0.171 0.586 0.397 0.140 0.663 0.409
ASEs 3.009 0.866 0.001 2.639 0.638 <0.001 2.422 0.673
TLEs 0.376 0.729 0.607 1.046 0.494 0.035 0.187 0.503
Allele 1.338 0.743 0.073 0.541 0.628 0.389 0.373 0.670
ASEsTLEs 1.625 0.959 0.091 1.749 0.764 0.023 2.412 0.779
AlleleASEs 0.366 0.924 0.693 0.313 0.922 0.734 0.204 0.826
AlleleTLEs 1.443 0.900 0.110 1.936 0.845 0.022 0.869 0.819
4 Age 0.355/0.018* 0.344 0.072 <0.001 0.335/0.006 0.344 0.061 <0.001 0.332/0 0.359 0.063
Sex 0.711 0.472 0.133 0.611 0.396 0.123 0.663 0.410
ASEs 4.584 1.011 <0.001 2.195 0.678 0.001 2.468 0.749
TLEs 0.601 0.794 0.450 0.783 0.512 0.127 0.211 0.530
Allele 0.317 0.813 0.697 0.090 0.670 0.893 0.420 0.748
ASEsTLEs 1.178 1.346 0.382 2.471 0.851 0.004 2.338 0.937
AlleleASEs 3.145 1.507 0.038 2.562 1.499 0.088 0.347 1.297
AlleleTLEs 0.373 1.084 0.731 0.955 0.988 0.334 0.777 1.042
AlleleTLEsASEs 5.540 1.892 0.004 3.598 1.894 0.058 0.240 1.684
Abbreviations: ASEs, anomalous self-experiences; COMT, catechol-O-methyltransferase; DAT1, dopamine transporter 1; TLEs, traumatic life events; DRD2, dopamine D2 receptor.
Significant effects (p < 0.05) were marked with bold characters.
*Significant R2 changes (p < 0.05).
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abnormally salient stimuli [66]. On the other hand, aberrant salience
may result in diminished self-affection and hyperreflexivity, contrib-
uting to disturbed basic selfhood [64].
Various limitations of this study need to be taken into consider-
ation. Firstly, our sample was not large, and replication of findings in
an independent sample was not performed. Secondly, a cross-
sectional study design does not provide insights into causal associ-
ations. Finally, the use of a nonclinical sample can also be perceived
as potential limitation and does not allow for generalization of
findings over patients with psychotic disorders. However, this
approach is characterized by a lack of confounding factors related
to clinical symptoms, cognitive impairments, comorbidities, and
medication effects. Finally, the use of self-reports has been raised
as a limitation. However, there is evidence that assessment with self-
reports is characterized by high validity and reporting stability.
In summary, our results imply that the effect of interaction
between theDAT1VNTR polymorphism and TLEs on the level of
PLEs is limited to individuals with high levels of ASEs. These
results provide novel insights into the complexity of gene–
environment interactions by showing that simple models might
be insufficient in addressing the complexity of how genetic pre-
disposition together with environmental stress might lead to
subclinical psychotic experiences. Given that assessment of ASEs
provides a unified approach to understand highly diverse symp-
tomatology of schizophrenia, longitudinal and neurobiological
studies investigating their basis can unravel new pathways of
psychosis development.
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